98 related articles for article (PubMed ID: 21691255)
1. Mutagenesis of the putative nucleotide-binding domains of the multidrug resistance associated protein (MRP). Analysis of the effect of these mutations on MRP mediated drug resistance and transport.
Center MS; Zhu Q; Sun H
Cytotechnology; 1998 Sep; 27(1-3):61-9. PubMed ID: 19002783
[TBL] [Abstract][Full Text] [Related]
2. Gene Expression of Abcc2 and Its Regulation by Chicken Xenobiotic Receptor.
Gao Y; Deng H; Zhao Y; Li M; Wang L; Zhang Y
Toxics; 2024 Jan; 12(1):. PubMed ID: 38251011
[TBL] [Abstract][Full Text] [Related]
3. Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.
Pratt VM; Beyer BN; Koller DL; Skaar TC; Flockhart DA; Levy KD; Vance GH
J Mol Diagn; 2015 Mar; 17(2):201-5. PubMed ID: 25554586
[TBL] [Abstract][Full Text] [Related]
4. Competitive SNP-LAMP probes for rapid and robust single-nucleotide polymorphism detection.
Hyman LB; Christopher CR; Romero PA
Cell Rep Methods; 2022 Jul; 2(7):100242. PubMed ID: 35880021
[TBL] [Abstract][Full Text] [Related]
5. Impact of ABC Transporters in Osteosarcoma and Ewing's Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
Serra M; Hattinger CM; Pasello M; Casotti C; Fantoni L; Riganti C; Manara MC
Cells; 2021 Sep; 10(9):. PubMed ID: 34572110
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma.
Maillard M; Chevreau C; Le Louedec F; Cassou M; Delmas C; Gourdain L; Blay JY; Cupissol D; Bompas E; Italiano A; Isambert N; Delcambre-Lair C; Penel N; Bertucci F; Guillemet C; Plenecassagnes J; Foulon S; Chatelut É; Le Cesne A; Thomas F
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291741
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of Statin-Induced Myotoxicity.
Kee PS; Chin PKL; Kennedy MA; Maggo SDS
Front Genet; 2020; 11():575678. PubMed ID: 33193687
[TBL] [Abstract][Full Text] [Related]
8. A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China.
Wu L; Li Y; Song Y; Zhou D; Jia S; Xu A; Zhang W; You H; Jia J; Huang J; Ou X
Orphanet J Rare Dis; 2020 Mar; 15(1):74. PubMed ID: 32183854
[TBL] [Abstract][Full Text] [Related]
9. In vitro Transport Ability of
Lian G; Yuan J; Gao Y
Onco Targets Ther; 2020; 13():1413-1419. PubMed ID: 32110040
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.
Tecza K; Pamula-Pilat J; Lanuszewska J; Butkiewicz D; Grzybowska E
Oncotarget; 2018 Feb; 9(10):9114-9136. PubMed ID: 29507678
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.
Wen X; Joy MS; Aleksunes LM
Pharm Res; 2017 Aug; 34(8):1637-1647. PubMed ID: 28405913
[TBL] [Abstract][Full Text] [Related]
12. Effect of MRP2 and MRP3 Polymorphisms on Anastrozole Glucuronidation and MRP2 and MRP3 Gene Expression in Normal Liver Samples.
Edavana VK; Penney RB; Yao-Borengasser A; Starlard-Davenport A; Dhakal IB; Kadlubar S
Int J Cancer Res Mol Mech; 2015 Oct; 1(3):. PubMed ID: 26985457
[TBL] [Abstract][Full Text] [Related]
13. Clinical Perspectives on Targeting Therapies for Personalized Medicine.
Singer DR; Zaïr ZM
Adv Protein Chem Struct Biol; 2016; 102():79-114. PubMed ID: 26827603
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms in microRNA binding sites: implications in colorectal cancer.
Bhaumik P; Gopalakrishnan C; Kamaraj B; Purohit R
ScientificWorldJournal; 2014; 2014():547154. PubMed ID: 25654126
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics.
Manikandan M; Munirajan AK
OMICS; 2014 Feb; 18(2):142-54. PubMed ID: 24286505
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2).
Megaraj V; Zhao T; Paumi CM; Gerk PM; Kim RB; Vore M
Pharmacogenet Genomics; 2011 Aug; 21(8):506-15. PubMed ID: 21691255
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2.
Hirouchi M; Suzuki H; Itoda M; Ozawa S; Sawada J; Ieiri I; Ohtsubo K; Sugiyama Y
Pharm Res; 2004 May; 21(5):742-8. PubMed ID: 15180328
[TBL] [Abstract][Full Text] [Related]
18. Human multidrug resistance protein 2 transports the therapeutic bile salt tauroursodeoxycholate.
Gerk PM; Li W; Megaraj V; Vore M
J Pharmacol Exp Ther; 2007 Feb; 320(2):893-9. PubMed ID: 17108237
[TBL] [Abstract][Full Text] [Related]
19. Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport.
Järvinen E; Troberg J; Kidron H; Finel M
Mol Pharm; 2017 Oct; 14(10):3299-3311. PubMed ID: 28850245
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
